Agency / Source: GenScript Corporation

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Protein Signal Launches Another New Best Antibody - Mouse Anti-PEG Antibody - Protein Signal now offers a Mouse Anti-PEG Monoclonal Antibody (Catalog No.: A01795-100, A01795-500). This antibody is a new member of THE™ Elite series, which represents THE best quality antibody in the industry - GenScript.com
Protein Signal Launches Another New Best Antibody - Mouse Anti-PEG Antibody

 

PRZOOM - /newswire/ - Piscataway, NJ, United States, 2013/02/20 - Protein Signal now offers a Mouse Anti-PEG Monoclonal Antibody (Catalog No.: A01795-100, A01795-500). This antibody is a new member of THE™ Elite series, which represents THE best quality antibody in the industry - GenScript.com. 1548:HK

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

PEG (Polyethylene glycol) is a polyether compound with many applications, from industrial manufacturing to medicine. PEGylation, which is an FDA-approved method of protein drug delivery, is the process of covalently coupling non-toxic, hydrophilic PEG molecules to a larger molecule. PEG modification can reduce the drug immunogenicity and antigenicity, decelerate renal excretion, improve stability towards proteolysis, and increase its half-life in blood. Accurate and sensitive quantification of PEG conjugates is important for PEG conjugated product development and pharmaceutical study. The polyethylene glycol (PEG) antibody is a useful tool for the detection of PEGylated molecules.

Currently, Protein Signal is having a "Find a better PEG antibody" special, guaranteeing to refund the money if customers find any PEG antibody product better than Protein Signal's. Protein Signal will develop other related products this year, such as Anti-PEG Antibody ELISA kits and labeling antibodies.

Specifications:

• Applications: Qualified for ELISA Capturer & Detector, Competitive ELISA, Double Antigen Bridging ELISA, Western Blot, Immunohistochemistry.
• Specificity: High affinity for the PEG backbone. The antibody binds to a variety of PEGs such as PEG40K, PEG20K, PEG5K, PEG12, PEGylated drugs, and PEG conjugates.
• Immunogen: PEG conjugated to KLH.
• Purification Method: Affinity chromatography.
• Fusion Partner: Spleen cells were fused with SP2/0-Ag14 mouse myeloma cells.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: GenScript Corporation

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Protein Signal Launches Another New Best Antibody - Mouse Anti-PEG Antibody

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
GenScript |
Contact: Sally Wang - GenScript.com 
732-885-9188 sallyw[.]genscript.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any GenScript Corporation securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Press Releases From GenScript Corporation / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Press Releases:

Frost & Sullivan Awards Avance Clinical for Global Biotech CRO Excellence, Highlighting Agility, Responsiveness, Customer Value
BASF Declares Force Majeure for Selected Vitamin A, Vitamin E, and Carotenoid Products As Well As Selected Aroma Ingredients
Ono Pharmaceutical Co., Ltd Enters into A New Option and Research Collaboration Agreement with Monash University
Aragen Life Sciences Ltd Receives the 2024 Global Customer Value Leadership Award from Frost & Sullivan for Pioneering Excellence in Drug Discovery
Ipsen’s Iqirvo® Receives U.S. FDA Accelerated Approval as A First-in-class PPAR Treatment for Primary Biliary Cholangitis
Ipsen Presents Long-term Elafibranor Efficacy and Itch-related Quality of Life Data in Patients with Primary Biliary Cholangitis
HUB Organoids B.V. Awarded Frost & Sullivan’s 2024 Technology Innovation Leadership Award for Transforming Drug Development
Immunology Consultants Laboratory Rebrand Highlights R&D and Service Specializations
Ipsen and Skyhawk Therapeutics Announce RNA Targeting Research Collaboration in Rare Neurological Diseases
Transgene and NEC Present First Clinical Benefits of Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer At AACR 2024

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
.



PREMIUM Members


Visit  Limelon Advertising, Co.

Visit  JobsWare.com

Visit  RightITnow, Inc.







 
  ©2005-2024 PRZOOM - Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today